Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Nature, 2025

Translational genomics of osteoarthritis in 1,962,069 individuals

Hatzikotoulas K., Southam L., Stefansdottir L. et al.

Nature Cancer, 2025

Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis

Cousin S., Guégan J., Palmieri L. et al.

Brain and Behavior, 2025

Systemic Inflammatory Factors and Neuropsychiatric Disorders: A Bidirectional Mendelian Randomization Study

Wang H., Cheng Z., Xu Z. et al.

Cell, 2025

Human proteome distribution atlas for tissue-specific plasma proteome dynamics

Malmström E., Malmström L., Hauri S. et al.

GeroScience, 2025

Associations between plasma proteomic signatures and secondary sleep in older adults

Madhawa K., Svensson T., Nt H. et al.

Scientific Reports, 2025

Novel serum biomarker associations with 7 Tesla MRI-defined cortical lesions, leptomeningeal enhancement, and deep gray matter volume in early multiple sclerosis

Miclea A., Zurawski J., Healy B. et al.

Thrombosis Journal, 2025

Association of MTHFR missense variants with thromboembolic diseases and coagulation factor levels in European populations

Daghlas I., Wang M., Gill D.

npj Precision Oncology, 2025

Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Cui S., Zheng H., Xu Y. et al.

Arthritis & Rheumatology, 2025

Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development

Rachid Zaim S., Savage A., Gillespie M. et al.

Cell Genomics, 2025

Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity

Donoghue L., Benner C., Chang D. et al.

Cell Reports Medicine, 2025

Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Hu M., Oliveira A., Fang Z. et al.

Mediators of Inflammation, 2025

Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis

Wu Z., Yang J., Zhu Y. et al.

Neurological Research, 2025

Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study

Tan H., Chen H., Yan H. et al.

International Journal of Cancer, 2025

Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

Cooley V., Fortner R., Mukama T. et al.

Nature Medicine, 2025

Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial

Temba G., Pecht T., Kullaya V. et al.

Journal of Proteome Research, 2025

Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics

Su H., Gu X., Zhang W. et al.

Urolithiasis, 2025

Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis

Huang H., Wen Z., Li H. et al.

Diabetes Care, 2025

Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes

Xie R., Vlaski T., Trares K. et al.

Cell Reports, 2025

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert L., Rubio R., Martín-Pérez C. et al.

Proceedings of the National Academy of Sciences, 2025

Nuclear Galectin-1 promotes KRAS -dependent activation of pancreatic cancer stellate cells

Vinaixa J., Martínez-Bosch N., Gibert J. et al.

4555 publications